secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K
Filed at:   2026-08-03T11:00:38+00:00
Accession:  0001193125-26-329526
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autolus enters $250M senior secured notes facility with Perceptive; initial $75M drawn
--------------------------------------------------------------------------------

- Issued $75M Tranche 1 Notes under $250M facility; additional $175M available in three tranches subject to revenue milestones.
- Notes mature July 30, 2031; interest rate = 1-month SOFR + 3.50% floor + margin 6.75%-7.25% based on revenue.
- Issued warrant to Perceptive for 3.5M ADSs at $1.9314 (25% premium to 30-day VWAP); additional warrants for future tranches.
- Proceeds for general corporate purposes; facility secured by substantially all assets of company and guarantors.
- Financial covenants: minimum liquidity $12.5M-$50M and minimum consolidated net revenue thresholds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000119312526329526/0001193125-26-329526-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000119312526329526/d156965d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-329526

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer